{
  "id": "55031650e9bde69634000026",
  "type": "yesno",
  "question": "Is PTEN involved in follicular thyroid carcinoma?",
  "ideal_answer": "The PTEN mutation frequency in unselected cases of follicular thyroid carcinoma was 4.8%.",
  "documents": [
    "http://www.ncbi.nlm.nih.gov/pubmed/11297621",
    "http://www.ncbi.nlm.nih.gov/pubmed/16487009",
    "http://www.ncbi.nlm.nih.gov/pubmed/9832031",
    "http://www.ncbi.nlm.nih.gov/pubmed/21417916",
    "http://www.ncbi.nlm.nih.gov/pubmed/12203792",
    "http://www.ncbi.nlm.nih.gov/pubmed/18055323",
    "http://www.ncbi.nlm.nih.gov/pubmed/9790504"
  ],
  "snippets": [
    {
      "text": "Two of the 259 patients (0.8%), with both follicular thyroid carcinoma and macrocephaly, were found to carry a germline mutation in the PTEN gene. The PTEN mutation frequency in unselected cases of follicular thyroid carcinoma was 4.8%",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/21417916",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "The frequency of germline pathogenic PTEN mutations in an unselected series of patients with DTC is relatively low, but it is enriched by considering follicular histology and macrocephaly",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/21417916",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Similarly, there is increasing evidence demonstrating that mutations leading to activation of the phosphatidylinositol 3- kinase (PI3K)/AKT effectors -PTEN and PI3KCa- are essential for the pathogenesis of follicular thyroid carcinoma (FTC)",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/18055323",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "A single male with follicular thyroid carcinoma from one of these 64 (2%) CS-like families harboured a germline point mutation, c.209T-->C",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/9832031",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Similarly, there is increasing evidence demonstrating that mutations leading to activation of the phosphatidylinositol 3- kinase (PI3K)/AKT effectors -PTEN and PI3KCa- are essential for the pathogenesis of follicular thyroid carcinoma (FTC).",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/18055323",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "The transcriptional silencing of PTEN was significantly associated with the anaplastic subtype, suggesting that PTEN is involved in the carcinogenesis of highly malignant or late-stage thyroid cancers, whereas this particular mechanism appears to be of minor importance in differentiated follicular thyroid tumors.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/12203792",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "These results show a high frequency of PTEN promoter hypermethylation, especially in follicular tumors, suggesting its possible role in thyroid tumorigenesis",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/16487009",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Our findings suggest that the PTEN tumor suppressor gene is occasionally inactivated in sporadic follicular thyroid tumors",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/9790504",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Germline mutations in the tumor suppressor gene PTEN, which encodes a dual-specificity phosphatase, have been found in up to 80% of patients with Cowden syndrome suggesting a role of PTEN in the pathogenesis of follicular thyroid tumors",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/11297621",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "The most common neoplasms in Cowden disease patients arise in the breast, skin, and thyroid (follicular subtype)",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/9790504",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "The transcriptional silencing of PTEN was significantly associated with the anaplastic subtype, suggesting that PTEN is involved in the carcinogenesis of highly malignant or late-stage thyroid cancers, whereas this particular mechanism appears to be of minor importance in differentiated follicular thyroid tumors",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/12203792",
      "beginSection": "abstract",
      "endSection": "abstract"
    }
  ],
  "concepts": [
    "http://www.disease-ontology.org/api/metadata/DOID:3962",
    "http://www.uniprot.org/uniprot/PTEN_XENLA"
  ],
  "exact_answer": "Yes"
}